pulmonary-hypertension

Documents about pulmonary-hypertension

• Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.#890060ClinicalTrials.gov
• Imaging Control Study, 3D Echo, MR and RHC.#895846ClinicalTrials.gov
• Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)#897301ClinicalTrials.gov
• Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension#905462ClinicalTrials.gov
• Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension#910537ClinicalTrials.gov
• Ketones for Pulmonary Hypertension - Effects on Hemodynamics#918316ClinicalTrials.gov
• Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension#918357ClinicalTrials.gov
• Londrina Activities of Daily Living Protocol in Pulmonary Hypertension#979448ClinicalTrials.gov
• Telemonitoring to Treat Group 2 Pulmonary Hypertension#980881ClinicalTrials.gov
• Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)#373689ClinicalTrials.gov
• Ventavis® Registry Protocol#405227ClinicalTrials.gov
• The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension#67736ClinicalTrials.gov
• A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension#180237ClinicalTrials.gov
• Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator Testing#261397ClinicalTrials.gov
• Successful Completion of High-Risk Neuroblastoma Therapy After Stabilization of Pulmonary Hypertension With Tadalafil#322697Kyoto University Research Information Repository
• Successful Completion of High-Risk Neuroblastoma Therapy After Stabilization of Pulmonary Hypertension With Tadalafil#322705Kyoto University Research Information Repository
• A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension#325183ClinicalTrials.gov
• Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients#329391ClinicalTrials.gov
• Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension#329428ClinicalTrials.gov
• Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension#332837ClinicalTrials.gov
• Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease#454088ClinicalTrials.gov
• Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure#827688ClinicalTrials.gov
• Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)#827692ClinicalTrials.gov
• Quantitative Dual Energy Computed Tomography in Pulmonary Hypertension#847028ClinicalTrials.gov
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension#847905ClinicalTrials.gov
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension#853281ClinicalTrials.gov
• Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension#856399ClinicalTrials.gov
• The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension#903310ClinicalTrials.gov
• Ventricular Reversed Remodeling After LTX in PAH Patients#909403ClinicalTrials.gov
• Pulmonary Vascular Disease Phenomics Program PVDOMICS#858232ClinicalTrials.gov
• Wave Intensity Analysis in the Pulmonary Artery#894335ClinicalTrials.gov
• Prognostic Value of the Right Ventricular Function by Portable Ultrasound in Patients With Pulmonary Hypertension.#805065ClinicalTrials.gov
• Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment#826739ClinicalTrials.gov
• Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)#913347ClinicalTrials.gov
• To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis#914143ClinicalTrials.gov
• Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension#234555ClinicalTrials.gov
• Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study#898158ClinicalTrials.gov
• The Risk of Adverse Pregnancy Outcomes for Long-term Exposure to Air Pollution in Pregnant Patients With Pulmonary Hypertension#853406ClinicalTrials.gov
• Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction#876883ClinicalTrials.gov
• The Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension#158104ClinicalTrials.gov
• Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects#226150ClinicalTrials.gov
• A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study#245392ClinicalTrials.gov
• Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension#303627ClinicalTrials.gov
• Recurrence of Pulmonary Hypertension After Unilateral Lung Transplantation: Histological Evidence of Vasoconstrictive Mechanism#416031OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System#471554ClinicalTrials.gov
• A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.#802772ClinicalTrials.gov
• Evaluation of a New 6 Minute Walk Test Smartphone App in Patients With Pulmonary Hypertension#847422ClinicalTrials.gov
• imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce#916843ClinicalTrials.gov
• High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)#256988ClinicalTrials.gov
• Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD#424295ClinicalTrials.gov